George Hill
Stock Analyst at Deutsche Bank
(2.95)
# 1,423
Out of 5,131 analysts
190
Total ratings
54.39%
Success rate
6.08%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Downgrades: Hold | $332 → $320 | $374.97 | -14.66% | 3 | Dec 19, 2025 | |
| HUM Humana | Maintains: Hold | $250 → $231 | $276.59 | -16.48% | 12 | Nov 7, 2025 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $825.62 | +3.68% | 8 | Sep 24, 2025 | |
| HQY HealthEquity | Maintains: Buy | $98 → $115 | $84.56 | +36.00% | 18 | Jun 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $340.51 | +6.31% | 22 | May 14, 2025 | |
| CVS CVS Health | Maintains: Buy | $66 → $70 | $80.36 | -12.89% | 7 | Feb 14, 2025 | |
| AGL agilon health | Maintains: Hold | $4 → $2 | $0.99 | +102.76% | 16 | Nov 8, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $23 → $27 | $32.34 | -16.51% | 4 | Nov 6, 2024 | |
| CI The Cigna Group | Maintains: Buy | $398 → $394 | $276.02 | +42.74% | 10 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Hold | $119 → $124 | $202.52 | -38.77% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $12 | $7.25 | +65.52% | 18 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $4.00 | -50.00% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $31.59 | -1.87% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $2.54 | +96.85% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $46.39 | +87.54% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $181.82 | +94.15% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $296.92 | +58.63% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.88 | +177.78% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $240.86 | +3.79% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $180.15 | +30.45% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $218.82 | +52.64% | 5 | Feb 18, 2021 |
Elevance Health
Dec 19, 2025
Downgrades: Hold
Price Target: $332 → $320
Current: $374.97
Upside: -14.66%
Humana
Nov 7, 2025
Maintains: Hold
Price Target: $250 → $231
Current: $276.59
Upside: -16.48%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $825.62
Upside: +3.68%
HealthEquity
Jun 5, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $84.56
Upside: +36.00%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $340.51
Upside: +6.31%
CVS Health
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $80.36
Upside: -12.89%
agilon health
Nov 8, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.99
Upside: +102.76%
Hims & Hers Health
Nov 6, 2024
Maintains: Hold
Price Target: $23 → $27
Current: $32.34
Upside: -16.51%
The Cigna Group
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $276.02
Upside: +42.74%
Cardinal Health
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $202.52
Upside: -38.77%
Nov 1, 2024
Maintains: Hold
Price Target: $10 → $12
Current: $7.25
Upside: +65.52%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $4.00
Upside: -50.00%
Aug 14, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $31.59
Upside: -1.87%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $2.54
Upside: +96.85%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $46.39
Upside: +87.54%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $181.82
Upside: +94.15%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $296.92
Upside: +58.63%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.88
Upside: +177.78%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $240.86
Upside: +3.79%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $180.15
Upside: +30.45%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $218.82
Upside: +52.64%